Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

UK biotech

- PMLiVE

RNA-focused biotech Storm Therapeutics raises extra £14m

New head of translational oncology also hired

- PMLiVE

Syncona launches another cell therapy company, Treg specialist Quell

Focuses on novel immune system approach

- PMLiVE

Tax credit changes could put a ‘hard brake’ on UK biotech

Anti-fraud measures will hit genuine firms, fears BIA

- PMLiVE

Bicycle Therapeutics looks to raise $86m with IPO

Key data readout expected later this year

- PMLiVE

New biotech accelerator launched in Cambridge, UK

Start Codon aims to invest in 50 start-up companies over the next five years

- PMLiVE

Merck KGaA exec takes top job at UK biotech Kymab

UK biotech veteran returns to head antibody specialist

- PMLiVE

Investments show UK biotech still booming despite Brexit

UK raised a quarter of all European biotech funds

- PMLiVE

UCB looks to pipeline with five years left for twin blockbusters

CEO outlines pipeline promise, won't write off post-Brexit UK

- PMLiVE

Ministerial revolt looming over ‘no-deal’ Brexit risk

Airbus CEO says no-deal Brexit could force it to relocate

Novartis Gehry Building

Novartis forges AI alliance with Oxford University

Part of Novartis drive to become 'data-driven' pharma company

- PMLiVE

Blackwood returns as new life sciences minister

Replaces James O’Shaughnessy at DHSC

- PMLiVE

Ex-Pharmacyclics CEO invests $25m in Summit

After Duchenne drug failure, UK biotech looks to new anti-infective

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links